Trials / Unknown
UnknownNCT04485988
Influence of Beta Blockers on Prognosis in Patients With Acute Myocardial Infarction Complicated With Normal Ejection Fraction
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 3,000 (estimated)
- Sponsor
- Chongqing Medical University · Academic / Other
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
To understand the effect of beta blockers on the prognosis of patients with acute myocardial infarction with preserved ejection fraction.
Detailed description
The use of beta blockers is an important component of drug therapy for myocardial infarction, but in some exceptional cases, evidence-based evidence for their use is insufficient, and we seek to understand the prognostic impact of beta blockers on patients enrolled in long-term follow-up.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Beta blocker | Duration of medication |
Timeline
- Start date
- 2015-07-01
- Primary completion
- 2020-12-01
- Completion
- 2021-07-01
- First posted
- 2020-07-24
- Last updated
- 2021-06-24
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04485988. Inclusion in this directory is not an endorsement.